NEONC TECHNOLOGIES HOLDINGS, INC. Increase (Decrease) in Deferred Compensation
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) reported Increase (Decrease) in Deferred Compensation of -$479.77 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredCompensation · last filed 2026-08-10
- NEONC TECHNOLOGIES HOLDINGS, INC. increase (decrease) in deferred compensation for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. increase (decrease) in deferred compensation for the quarter ending 2025-09-30 was $0.00.
- NEONC TECHNOLOGIES HOLDINGS, INC. increase (decrease) in deferred compensation for the quarter ending 2025-06-30 was -$189.67K.
- NEONC TECHNOLOGIES HOLDINGS, INC. increase (decrease) in deferred compensation for the quarter ending 2025-03-31 was -$290.11K, a 349.02% decline year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. increase (decrease) in deferred compensation for fiscal 2025 was -$479.77K, a 954.74% decline from fiscal 2024.
- NEONC TECHNOLOGIES HOLDINGS, INC. increase (decrease) in deferred compensation for fiscal 2024 was $56.13K.
| Period end | Increase (Decrease) in Deferred Compensation 3 month | Increase (Decrease) in Deferred Compensation 6 month | Increase (Decrease) in Deferred Compensation 9 month | Increase (Decrease) in Deferred Compensation 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | -$189.67K derived: sum of 3 quarters · filed 2026-08-10 | -$479.77K 10-K · filed 2026-03-31 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$189.67K derived: sum of 2 quarters · filed 2026-08-10 | -$479.77K 10-Q · filed 2025-11-14 | -$365.52K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$189.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$479.77K 10-Q · filed 2026-08-10 | -$365.52K derived: sum of 3 quarters · filed 2026-08-10 | -$434.37K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$290.11K 10-Q · filed 2026-05-15 | -$175.85K derived: sum of 2 quarters · filed 2026-05-15 | -$244.70K derived: sum of 3 quarters · filed 2026-05-15 | -$350.48K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $114.26K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $45.41K derived: sum of 2 quarters · filed 2026-03-31 | -$60.37K derived: sum of 3 quarters · filed 2026-03-31 | $56.13K 10-K · filed 2026-03-31 |
| 2024-09-30 | -$68.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$174.63K derived: sum of 2 quarters · filed 2025-11-14 | -$58.13K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | -$105.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-18 | $10.72K 10-Q · filed 2025-08-18 | ||
| 2024-03-31 | $116.50K 10-Q · filed 2025-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |